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[2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)-
amino]ethyl]amino]ethanethiolato(3-)-N2,N2,S2,S2]oxo-[1R-exo-exo)])-[99mTc]-technetium
(99mTc-TRODAT-1) and 123I-iodobenzamide (123I-IBZM) are radiotracers for brain dopamine pre-
and postsynaptic neuron imaging. The purpose of this study was to evaluate imaging parameters
and crossed energy interference using simultaneous single photon emission computed tomogra-
phy (SPECT) 99mTc and 123I data acquisition. A five-compartment brain striatal phantom was
filled with 99mTc and/or 123I radioactive solutions with different striatal-to-background ratios,
ranging from 3:1 to 9:1. SPECT data were acquired with energy window settings of 15% for the
centered window at 140 keV for 99mTc and a 10% asymmetric window at 159 keV for 123I. The
experiments were carried out using either individual (99mTc or 123I only) or both radionuclides.
The striatal-to-background ratios and energy crossed interference between 99mTc and 123I were
calculated. The phantom SPECT images demonstrated that the energy crossed interferences from
123I to 99mTc, and vice versa, were 22 ± 12.4% and 0.4 ± 1.0%, respectively. A net interference of
7.1 ± 4.0% for the counts in the 15% centered 99mTc window can be expected from 123I and a net
interference of 1.6 ± 3.3% for the counts in the 10% asymmetric 123I window was derived from
99mTc. The correlation of striatal-to-background ratios between single isotope and simultaneous
dual-isotope was excellent (R2 = 0.99). The imaging parameters used in this simultaneous dual-
isotope SPECT imaging could be used in future clinical practice for imaging patients with move-
ment disorders by using 99mTc-TRODAT-1 and 123I-IBZM. The striatal-to-background ratios were
not affected by the crossed interference between 99mTc and 123I.
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Dual-isotope imaging is a valuable technique to con-
currently investigate two different mechanisms with
radiotracers in a specific organ to identify the nature
of a lesion in an identical spatial registration. Para-
thyroid 201Tl/99mTc dual-isotope subtraction imaging
has been widely used since the 1980s. In the 1990s,
the dual-isotope cardiac single photon emission com-
puted tomography (SPECT) technique was devel-
oped for the diagnosis of acute myocarditis using
99mTc-pyrophosphate and 201Tl for the diagnosis of
coronary artery disease by stress and rest imaging in
one session using 99mTc-2-methoxyisobutylisonitrile
(99mTc-MIBI) and 201Tl [1,2]. However, these images are
noisy due to the unfavorable physical properties of
201Tl, the down-scatter of 99mTc photons [2], and the
5–10-fold higher activity of 99mTc (10–20 mCi) than
201Tl (2 mCi) in clinical use.
Dual-isotope studies with 99mTc and 123I may be
useful for various organs, including the brain [3,4]
and myocardium [5]. Sequential injection of 123I-N-
isopropyl-p-iodoamphetamin (123I-IMP) and 99mTc-
hexamethylpropyleneamine oxime (99mTc-HMPAO) in
subjects under control and Diamox-stressed condi-
tions was developed to evaluate changes in regional
cerebral blood flow by SPECT imaging [3]. Although
99mTc and 123I have excellent physical properties for
SPECT imaging, the similarity of the photo-peak
energies (140 keV vs. 159 keV) between these two iso-
topes may interfere with image information, particu-
larly if the energy windows of each isotope cannot be
set properly [4]. Therefore, it is important to define
the optimal energy windows and to measure the
cross interference between these two isotopes in each
laboratory before performing simultaneous 99mTc/123I
dual-isotope SPECT.
The feasibility of simultaneous dual radionuclide
brain imaging with 99mTc and 123I using photo-peak
image subtraction techniques or offset photo-peak
image acquisition have been evaluated with a phan-
tom brain simulation for regional cerebral blood 
flow [6]. However, the images are affected by scatter,
cross-talk, attenuation, distance-dependent collima-
tor responses, and partial-volume effect [7]. There-
fore, the parameters used for simultaneous 99mTc/123I
assessment of regional cerebral cortex blood flow
may not be adequate for radiotracers that specifically
concentrate on the striatal region, or those that
become concentrated in the center of the cerebral
hemispheres.
With the development of 99mTc-TRODAT-1 as a
99mTc-labeled radiotracer for presynaptic dopamine
transporter imaging [8] and the availability of 
123I-IBZM as a 123I-labeled radiotracer for dopamine
D2/D3 receptor imaging [9], the simultaneous dual-
isotope SPECT imaging technique has had a consid-
erable impact on imaging the brain dopaminergic
system in patients with movement disorders [10].
In Taiwan, both 99mTc-TRODAT-1 and 123I-IBZM
are available from the Institute of Nuclear Energy
Research of the Atomic Energy Council. The dual-
isotope SPECT imaging technique offers a great
opportunity for researchers to aid differential diag-
nosis, to evaluate the severity, and to monitor disease
progression in patients with movement disorders.
The purpose of this study was to evaluate the energy
cross-interference between 99mTc and 123I with an off-
peak energy window setting for 123I in a simultaneous
99mTc-TRODAT-1 and 123I-IBZM dual-isotope SPECT
acquisition and to correlate the image results from a
phantom brain striatal preparation at different striatal-
to-background ratios.
MATERIALS AND METHODS
Phantom preparation
A commercially available, dedicated, five-compart-
ment striatal phantom (RSD Inc., Long Beach, CA,
USA) was used for all studies. This tissue-equivalent
anthropomorphic brain phantom consists of a left
caudate nucleus (LC), right caudate nucleus (RC), left
putamen (LP), right putamen (RP) and the remainder
of the brain as one compartment. Each compartment
was filled with radioactive solutions (99mTc, 123I or
both) to simulate the accumulation of 99mTc-TRODAT-1
and 123I-IBZM in the brain.
For all experiments, two different radioactive con-
centration solutions were prepared, one for the striatal
chambers (LC, RC, LP and RP) as a target organ and
the other for the rest of the brain as a background
chamber. The solutions were diluted according to the
different striatum-to-background ratios (3:1, 6:1 or 9:1)
for the individual experiments. In separate experi-
ments, the striatal chambers and the background
chamber were filled with solutions containing 99mTc
only, 123I only, or both radioisotopes. The actual filling
activities and the resulting experimental ratios are
summarized in Table 1.
Image acquisition and processing
A triple-head gamma camera (Siemens MultiSPECT3;
Siemens AG, Munich, Germany) equipped with ultra-
high resolution fan-beam collimators was used for
SPECT image acquisition. The acquisition parameters
comprised a rotational radius of 13.9 cm, 120 projec-
tion angles over 360° with 30 seconds/projection and
a 128×128 matrix size. The energy window was cen-
tered at 140 keV with a 15% window for 99mTc and a
10% asymmetric window with a lower bound at
159 keV for 123I. This window setting combination re-
presents a compromise between cross-interference
and count statistics. The projection images were recon-
structed by filtered back-projection with a Butterworth
filter and Chang’s first order for uniform attenuation
correction.
Data analysis
Regions of interest in the caudate nucleus, the puta-
men and the occipital areas were drawn based on 
a magnetic resonance image. The relative activity
ratios were calculated by dividing the mean counts
per pixel in the four chambers (target) with the mean
counts per pixel in the occipital area (background).
To calculate the crossed interference, for example
the 123I counts (measured by a 10% asymmetric 123I
window) crossed interference into 99mTc energy win-
dow was calculated as follows:
123I cross interference into 99mTc window =
99mTc count/pixel/μCi in dual-isotope study
− 99mTc count/pixel/μCi in single-isotope study
123I count/pixel/μCi in single-isotope study
The net interference from 123I on the 99mTc count 
at a 15% centered 99mTc window was calculated as
follows:
99mTc count/pixel/μCi in dual-isotope study
− 99mTc count/pixel/μCi in single-isotope study
99mTc count/pixel/μCi in single-isotope study
The reproducibility of the counting activity and the
different target/background ratios for each isotope
were determined. The correlation for striatal-to-
background ratios between the single isotopes and
simultaneous dual-isotope SPECT was calculated by
least square regression analyses.
RESULTS
Based on the average count (count/pixel/μCi), the
down-scattering of 123I into the 99mTc window was
99mTc/123I dual-isotope brain SPECT
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Table 1. Isotope concentrations in the striatum and background of the phantom brain
Filling activity (μCi/mL)
Target ratio
Striatum Background Real ratio
99mTc only
3:1 0.626 0.202 3.10
6:1 1.141 0.188 6.07
9:1 1.506 0.167 9.02
123I only
3:1 0.167 0.057 2.93
6:1 0.286 0.048 5.97
9:1 0.435 0.047 9.26
Mixed
3:1 99mTc 0.617 0.199 3.10
123I 0.171 0.056 3.06
6:1 99mTc 1.115 0.190 5.87
123I 0.287 0.047 6.10
9:1 99mTc 1.492 0.165 9.04
123I 0.426 0.046 9.27
22.0±12.4% of the 123I counts measured in a 10% asym-
metric 123I window (Table 2). Using the asymmetric 123I
window, only 0.4 ± 1.0% of the counts in that window
were from 99mTc. A net interference of 7.1 ± 4.0% of the
counts in a 15% centered 99mTc window was from 123I
and a net interference of 1.6 ± 3.3% of the counts in a
10% asymmetric 123I window was from 99mTc.
Qualitatively, the images of the single- and dual-
isotope studies did not differ significantly. Transverse
images of the 99mTc and 123I simultaneous dual-isotope
striatal phantom SPECT were prepared and possible
artifacts due to septal penetration of the high ener-
getic 123I photons were not observed (Figure).
There was a good correlation (R2 = 0.99) for the
striatum-to-background ratios obtained from SPECT
results between the single- and dual-isotope images
of both 99mTc and 123I isotopes (Table 3).
DISCUSSION
With the development of 99mTc-TRODAT-1 as 99mTc-
labeled DAT ligand [8] and the availability of 123I-IBZM
as 123I-labeled dopamine D2/D3 receptor ligand [9],
simultaneous dual-isotope SPECT imaging has con-
siderable impact on imaging the brain dopaminergic
system in patients with movement disorders. With
successful simultaneous 99mTc-TRODAT-1 and 123I-
IBZM dual-isotope SPECT in baboon [10] and monkey
[11] studies, this imaging technique has enormous
potential in neurology and psychiatry to aid in not
only differential diagnosis but also in monitoring
treatment response [12]. In Taiwan, both 99mTc-TRO-
DAT-1 and 123I-IBZM are available from the Institute
of Nuclear Energy Research of the Atomic Energy
Council. It is a great opportunity for researchers in
Taiwan to use 99mTc-TRODAT-1 and 123I-IBZM dual-
isotope SPECT in patients with neurological and psy-
chiatric disorders. Simultaneous 99mTc-TRODAT-1 and
123I-IBZM imaging is a powerful technique to image
the dopamine system under the same physiological
status with a very accurate spatial registration. This
technique also saves time on data acquisition; patients
can complete two studies in one visit, which is impor-
tant for movement disorder patients. Therefore, it is
of great clinical interest to be able to simultaneously
image two functionally separate binding sites within
the same organ.
Simultaneous dual-isotope imaging is particularly
desirable if two radiopharmaceuticals labeled with
different isotopes bind to functionally different sites
or display functions in different physiologic stages in
the same anatomical area. Dual-isotope acquisitions
produce images that are in highly accurate spatial reg-
istration with each other. Therefore, analytical errors
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Figure. 99mTc/123I dual-isotope single photon emission computed
tomography of the striatal phantom with a 6:1 striatal-to-back-
ground ratio shows homogeneous background activity and
prominent striatal activity.
Table 2. Mean counts/pixel for single- and dual-isotope experiments at different ratios
Targeted ratio
3:1 counts/pixel 6:1 counts/pixel 9:1 counts/pixel Interference 
tg bkg tg bkg tg bkg
(%)
99mTc dual-isotope 685.6 326.2 1,037.1 306.7 1,390.2 261.8 22.0 ± 12.4
99mTc single-isotope 630.9 302.8 1,032.7 275.1 1,383.9 245.0
123I dual-isotope 57.0 26.2 103.5 20.1 96.2 21.2 0.4 ± 1.0
123I single-isotope 56.0 26.9 100.1 22.0 102.1 21.6
tg = striatum; bkg = background.
due to different positions of the subject in two differ-
ent scans can be minimized. The images shown in the
Figure indicate the identical transverse image slices
of 99mTc-TRODAT-1 and 123I-IBZM without software
coregistration. Furthermore, physiologic differences in
ligand binding due changes in blood flow and differ-
ent receptor status, with or without medication, can
be eliminated. These factors may affect the results of
studies performed on different days.
Despite the above-mentioned advantages, dual-
isotope imaging approaches could potentially produce
degraded and interfered images due to the excess
labeling of the second radioisotope [3,4]. Close atten-
tion to several important factors is required to produce
accurate images that reflect the distribution of each
isotope. The factors include optimal energy window
settings, energy-dependent uniformity, and the degree
of interference (cross-talk) in separate and simultane-
ous acquisition of dual-isotope imaging [3,4]. In this
study, we demonstrated an appropriate energy win-
dow setting, which resulted in a good correlation for
the striatal-to-background ratios between single- and
dual-isotope imaging in both 99mTc-TRODAT-1 and
123I-IBZM images.
In this study, we focused on striatal uptake of 99mTc-
TRODAT-1 and 123I-IBZM using a striatal phantom
with attenuating media and background activity in
the brain shell to represent the clinical situation of the
dopaminergic system as closely as possible. A SPECT
equipped with ultra-high resolution fan-beam collima-
tors was used for all of our experiments, instead of
conventional parallel hole-collimators to increase the
resolution for clinical use. With a 15% asymmetric
energy window for 99mTc, the down-interference by 123I
was high (22%), but the net interference was only 7.1%
because the 99mTc activity (25 mCi) was five times
higher than that of 123I (5 mCi) in current clinical use.
However, it is important to note that our results
are appropriate only for very specific equipment, i.e.
the type of collimators used, the specific acquisition
protocols and the reconstruction procedures that we
currently use [13]. For example, a lower-resolution
collimator or a different reconstruction filter could
possibly alter the magnitude of the effects observed.
Therefore, every nuclear medicine department that
intends to use 99mTc-TRODAT-1 and 123I-IBZM dual-
isotope SPECT for human striatal dopaminergic imag-
ing must perform a similar phantom study with
specific collimators and reconstruction parameters to
evaluate the appropriateness of the imaging protocol
for clinical use. Here, we demonstrated the principle
and the results of our experiment as a paradigm to eval-
uate the parameters with a specific SPECT instru-
ment and imaging reconstruction methods.
CONCLUSION
The data presented in this report are derived from
dedicated striatal phantom studies and suggest that
simultaneous dual-isotope SPECT imaging of the
striatum using 99mTc-labeled and 123I-labeled radio-
pharmaceuticals is feasible. Comparable image qual-
ity and striatal-to-background ratios were observed
for the single- and dual-isotope experiments. The
success of this simultaneous dual-isotope SPECT
technique reported here warrants further studies
using 99mTc-TRODAT-1/123I-IBZM simultaneous dual-
isotope SPECT for both dopamine transporter/
D2 receptor imaging in the differential diagnosis
99mTc/123I dual-isotope brain SPECT
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Table 3. Comparison between the real and scan results of striatal-to-background ratios and the regression of the dual-
isotope results to the single-isotope results
Target ratios Regression
3:1 6:1 9:1 Dual/Single
99mTc dual-isotope Real ratio 3.10:1 5.87:1 9.04:1 R2 = 0.99
Scan ratio 2.10:1 3.38:1 5.31:1
99mTc single-isotope Real ratio 3.10:1 6.07:1 9.02:1
Scan ratio 2.08:1 3.75:1 5.65:1
123I dual-isotope Real ratio 3.06:1 6.10:1 9.27:1 R2 = 0.99
Scan ratio 2.18:1 4.65:1 5.49:1
123I single-isotope Real ratio 2.93:1 5.97:1 9.26:1
Scan ratio 2.08:1 4.55:1 5.64:1
between Parkinson’s disease and other movement
disorders.
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99m
Tc-TRODAT-1 及 
123
I-IBZM 分別是腦部多巴胺神經傳導系統的突觸前及突觸後的
放射性造影劑。本研究目標是要評估同時間 
99m
Tc 及 
123
I 雙核種腦部單光子電腦斷層
造影時，影像收錄條件與雙核種間能窗重疊干擾所造成的影響。本研究應用一個分成
五個腔室的腦部紋狀假體，在腔室中注入不等濃度的 
99m
Tc 及 / 
123
I或放射性溶液，
將紋狀體和背景值比率調整成 1：3 至 1：9。單光子斷層掃描收錄 
99m
Tc 採用 140 
keV 開 15% 對稱能窗，收錄 
123
I 則為 159 keV 開 10% 不對稱能窗。實驗包含單一
放射製劑 (
99m
Tc 或 
123
I) 和合併兩種放射製劑兩部份。實驗結果將計算紋狀體對背景
的比值以及 
99m
Tc 與 
123
I 能量重疊干擾。假體實驗證實從 
123
I 進入 
99m
Tc 的能量重疊
干擾為 22 ± 12.4%，反之則為 0.4 ± 1.0%。
99m
Tc 影像中的淨干擾來自 
123
I 的活性
佔 7.1 ± 4%，反之則為 1.6 ± 3.3%。計算紋狀體—背景值在單一放射核種與同時
間雙核種收錄影像結果之間的相關性極佳 (R
2
 = 0.99)。本研究結果使用的能窗設定參
數能應用在未來動作障礙病患所進行 
99m
Tc-TRODAT-1 及 
123
I-IBZM 的同時間雙核
種單光子電腦斷層掃描。計算 
99m
Tc 及 
123
I 的紋狀體—背景值的結果將不受能窗重疊
干擾的影響。
關鍵詞：
123
I-IBZM，
99m
Tc-TRODAT-1，腦部紋狀假體，單光子電腦斷層造影
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